Clinical Trial

Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated May 4, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a phase I/II protocol investigating whether Nelfinavir can improve anemia and lower serum fibrosis biomarkers in Myelofibrosis patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-04; most recent amendment 2026-04-28.
Trial Details
NCT Number NCT07281781
Lead Sponsor University of California, Irvine
Conditions Myelofibrosis, Myelofibrosis; Anemia
Enrollment 10 participants
Start Date 2025-09-16
Primary Completion 2026-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-04